Negash Kassahun, Macleod Colin, Adamu Yilikal, Ahmed Mohammed, Ibrahim Mohamed, Ali Mussa, Haileselassie Tesfaye, Willis Rebecca, Chu Brian K, Dejene Michael, Asrat Atsbeha, Flueckiger Rebecca M, Pavluck Alexandre L, Solomon Anthony W
a AMREF Health Africa , Addis Ababa , Ethiopia.
b Clinical Research Department , London School of Hygiene & Tropical Medicine , London , UK.
Ophthalmic Epidemiol. 2018 Dec;25(sup1):3-10. doi: 10.1080/09286586.2017.1362008.
Trachoma is to be eliminated as a public health problem by 2020. To help the process of planning interventions where needed, and to provide a baseline for later comparison, we set out to complete the map of trachoma in Afar, Ethiopia, by estimating trachoma prevalence in evaluation units (EUs) of grouped districts ("woredas").
We conducted seven community-based surveys from August to October 2013, using standardised Global Trachoma Mapping Project (GTMP) survey methodologies.
We enumerated 5065 households and 18,177 individuals in seven EUs covering 19 of Afar's 29 woredas; the other ten were not accessible. 16,905 individuals (93.0%) were examined, of whom 9410 (55.7%) were female. One EU incorporating four woredas (Telalak, Dalefage, Dewe, Hadele Ele) was shown to require full implementation of the SAFE strategy for three years before impact survey, with a trachomatous inflammation-follicular (TF) prevalence in 1-9-year-olds of 17.1% (95%CI 9.4-25.5), and a trichiasis prevalence in adults aged ≥15 years of 1.2% (95%CI 0.6-2.0). Five EUs, covering 13 woredas (Berahle, Aba'ala, Dupti, Kurri, Elidihare, Ayesayeta, Afamboo, Bure Mudaitu, Gewane, Amibara, Dulecho, Dalolo, and Konebo), had TF prevalences in children of 5-9.9% and need one round of azithromycin mass treatment and implementation of the F and E components of SAFE before re-survey; three of these EUs had trichiasis prevalences in adults ≥0.2%. The final EU (Mile, Ada'ar) had a sub-threshold TF prevalence and a trichiasis prevalence in adults just >0.2%.
Trachoma is a public health problem in Afar, and implementation of the SAFE strategy is required.
到2020年要消除沙眼这一公共卫生问题。为协助在必要之处规划干预措施的进程,并提供后续比较的基线,我们着手通过估算埃塞俄比亚阿法尔州各群组行政区(“沃雷达斯”)评估单元(EUs)的沙眼患病率来完成阿法尔州的沙眼地图绘制。
我们于2013年8月至10月开展了七项基于社区的调查,采用标准化的全球沙眼地图绘制项目(GTMP)调查方法。
我们在涵盖阿法尔州29个沃雷达斯中19个的七个评估单元中统计了5065户家庭和18177人;另外十个无法进入。检查了16905人(93.0%),其中9410人(55.7%)为女性。有一个包含四个沃雷达斯(特拉拉克、达莱法格、德韦、哈德莱埃莱)的评估单元显示,在进行影响调查前需要全面实施SAFE策略三年,1至9岁儿童的沙眼性炎症 - 滤泡型(TF)患病率为17.1%(95%CI 9.4 - 25.5),≥15岁成年人的倒睫患病率为1.2%(95%CI 0.6 - 2.0)。五个评估单元,涵盖13个沃雷达斯(贝拉赫勒、阿巴阿拉、杜皮、库里、埃利迪哈雷、阿耶塞耶塔、阿方布、布雷穆代图、格瓦内、阿米巴拉、杜莱乔、达洛洛和科内博),5至9岁儿童的TF患病率为5 - 9.9%,在重新调查前需要进行一轮阿奇霉素群体治疗并实施SAFE策略的F和E部分;其中三个评估单元≥15岁成年人的倒睫患病率≥0.2%。最后一个评估单元(迈勒、阿达阿尔)的TF患病率低于阈值,成年人倒睫患病率略高于0.2%。
沙眼在阿法尔州是一个公共卫生问题,需要实施SAFE策略。